|
|
|
Volumn 28, Issue 3, 2003, Pages 191-203
|
|
Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSTIC AGENT;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
RECOMBINANT PROTEIN;
THYROGLOBULIN;
THYROTROPIN;
THYROXINE;
ADULT;
AGED;
ARTICLE;
BLOOD;
COHORT ANALYSIS;
COMPARATIVE STUDY;
ECHOGRAPHY;
EVALUATION;
FEMALE;
FOLLOW UP;
HORMONE SUBSTITUTION;
HUMAN;
MALE;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
PAPILLARY CARCINOMA;
PATHOLOGY;
SCINTISCANNING;
SECRETION;
SENSITIVITY AND SPECIFICITY;
THYROID TUMOR;
TUMOR RECURRENCE;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, PAPILLARY;
COHORT STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HORMONE REPLACEMENT THERAPY;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM, RESIDUAL;
RADIOPHARMACEUTICALS;
RECOMBINANT PROTEINS;
SENSITIVITY AND SPECIFICITY;
TECHNETIUM TC 99M SESTAMIBI;
THYROGLOBULIN;
THYROID NEOPLASMS;
THYROTROPIN;
THYROXINE;
|
|
EID: 1542294345
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
